Ralf Wilkowski

Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Gemcitabine Alone in Advanced Pancreatic Cancer

Volker Heinemann, D. Quietzsch, Frank Gieseler et al. · Journal of Clinical Oncology · 2006 · 682 citations

Antiangiogenic Therapy with Mammalian Target of Rapamycin Inhibitor RAD001 (Everolimus) Increases Radiosensitivity in Solid Cancer

Philipp Manegold, Carmen Paringer, Ulrike Kulka et al. · Clinical Cancer Research · 2008 · 108 citations

Randomized trial with early-stage Hodgkin's disease testing 30 Gy vs. 40 Gy extended field radiotherapy alone

E. Dühmke, Volker Diehl, Markus Loeffler et al. · International Journal of Radiation Oncology*Biology*Physics · 1996 · 80 citations

Adaptive Radiotherapy, Field Radiotherapy, Radiation Medicine +6

Combined chemoradiotherapy for isolated local recurrence after primary resection of pancreatic cancer.

Ralf Wilkowski, Martin Thoma, Christiane J. Bruns et al. · PubMed · 2006 · 71 citations

Are Serial CA 19-9 Kinetics Helpful in Predicting Survival in Patients with Advanced or Metastatic Pancreatic Cancer Treated with Gemcitabine and Cisplatin?

P Stieber, A.M. Szymala, Andreas Schalhorn et al. · Oncology Research and Treatment · 2003 · 69 citations · Full text